Glofitamab Step-up Dosing Induces High Response Rates in Patients (pts) with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL), Most of Whom Had Failed Prior Bruton's Tyrosine Kinase Inhibitor (BTKi) Therapy
暂无分享,去创建一个
J. Zaucha | N. Bartlett | T. Phillips | C. Carlo-Stella | M. Crump | E. Clark | M. Dickinson | M. Trněný | F. Morschhauser | D. Carlile | E. Bachy | K. Humphrey | D. Pérez-Callejo | L. Lundberg | J. Relf | Audrey Filézac de L'Étang | A. Filézac de L'Étang